Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Wenzel

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
European Urology Oncology|June 4, 2026
Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 StudyPhilipp Cornelius Mandel, Mike Wenzel, María Natalia Gandur Quiroga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 StudyGazanfer Belge, Cansu Dumlupinar, Tim Nestler, et al.
World Journal of Urology|August 10, 2025
The perks of combining extension and Gleason score of positive surgical margins after robot-assisted radical prostatectomyStefano Tappero, Daniele Amparore, Mike Wenzel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 24, 2025
Robot-assisted radical nephroureterectomy for locally advanced upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Working Group on Robot-assisted SurgeryFabrizio Di Maida, Carlo Andrea Bravi, Ruben De Groote, et al.
World Journal of Urology|April 11, 2026
Anatomical distribution and predictors of lymph node metastasis in robot-assisted radical nephroureterectomy for upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Robotic Surgery Working GroupFabrizio Di Maida, Luca Lambertini, Carlo Andrea Bravi, et al.
The Prostate|September 24, 2025
Robot-Assisted Salvage Prostatectomy: External Validation of the EAU Selection Criteria and Identification of the Optimal Candidate: A Junior ERUS/YAU Collaborative StudyMike Wenzel, Christoph Würnschimmel, Arjun Nathan, et al.
World Journal of Urology|May 9, 2025
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative studyMike Wenzel, Christoph Würnschimmel, Marcio Covas Moschovas, et al.
The Prostate|July 24, 2025
Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative StudyMike Wenzel, Arjun Nathan, Marcio Covas Moschovas, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 studyThomas Büttner, Mimma Rizzo, Laura Bernal Vaca, et al.
European Urology Open Science|April 13, 2026
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsPhilipp Mandel, Mike Wenzel, Felix Chun, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
European Urology Oncology|June 4, 2026
Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 StudyPhilipp Cornelius Mandel, Mike Wenzel, María Natalia Gandur Quiroga, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 StudyGazanfer Belge, Cansu Dumlupinar, Tim Nestler, et al.
World Journal of Urology|August 10, 2025
The perks of combining extension and Gleason score of positive surgical margins after robot-assisted radical prostatectomyStefano Tappero, Daniele Amparore, Mike Wenzel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 24, 2025
Robot-assisted radical nephroureterectomy for locally advanced upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Working Group on Robot-assisted SurgeryFabrizio Di Maida, Carlo Andrea Bravi, Ruben De Groote, et al.
World Journal of Urology|April 11, 2026
Anatomical distribution and predictors of lymph node metastasis in robot-assisted radical nephroureterectomy for upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Robotic Surgery Working GroupFabrizio Di Maida, Luca Lambertini, Carlo Andrea Bravi, et al.
The Prostate|September 24, 2025
Robot-Assisted Salvage Prostatectomy: External Validation of the EAU Selection Criteria and Identification of the Optimal Candidate: A Junior ERUS/YAU Collaborative StudyMike Wenzel, Christoph Würnschimmel, Arjun Nathan, et al.
World Journal of Urology|May 9, 2025
The effect of lymph node dissection on oncological outcomes in contemporary robotic salvage radical prostatectomy patients: a junior ERUS/YAU collaborative studyMike Wenzel, Christoph Würnschimmel, Marcio Covas Moschovas, et al.
The Prostate|July 24, 2025
Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative StudyMike Wenzel, Arjun Nathan, Marcio Covas Moschovas, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 studyThomas Büttner, Mimma Rizzo, Laura Bernal Vaca, et al.
European Urology Open Science|April 13, 2026
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway InhibitorsPhilipp Mandel, Mike Wenzel, Felix Chun, et al.
Pageof 22